(24MTHS)Phase I/II Feasibility Study of Cetuximab With or Without Cisplatin With Concurrent Radiotherapy in Muscle Invasive Bladder Cancer

James, Nicholas (Principal Investigator)
Hussain, Syed (Co-Investigator)

Cancer and Genomic Sciences

1 Article

1 results

2022
TUXEDO: A phase I/II trial of cetuximab with chemoradiotherapy in muscle-invasive bladder cancer
TUXEDO investigators, 31 Jul 2022, (E-pub ahead of print) In: BJU International .
Research output: Contribution to journal › Article › peer-review

Open Access
File
30 Downloads (Pure)